Congress demands documents from FDA on controversial approval of Biogen’s Alzheimer’s drug
(By Rachel Cohrs for STAT) WASHINGTON — Lawmakers have requested data and documents from the Food and Drug Administration related
Read moreAlzheimer’s/Dementia
Biogen offering Aduhelm free-to-charge to some healthcare providers
Biogen, Inc., the maker of the controversial and expensive new Alzheimer’s drug, is offering the medication free of charge for
Read moreWhy Alzheimer’s disease affects one region of the brain and not the others
In a recent study published in Nature Neuroscience, researchers said, “if we understood why these neurons are so vulnerable, maybe
Read moreTranscranial magnetic stimulation a possible treatment for Alzheimer’s disease
Around 6.2 million Americans aged 65 and older are living with Alzheimer’s disease. With no effective interventions for disease prevention
Read moreClarity on Covid Count: Pandemic’s Toll on Seniors Extended Well Beyond Nursing Homes
(By Judith Graham for Kaiser Health News) As covid-19 resurges across the country, driven by the highly infectious delta variant,
Read moreNew scanning technology could help diagnose Alzheimer’s disease using light
(Source – www.blogs.va.gov) Researchers with the VA Bedford and VA Boston health care systems have developed a non-invasive optical technique
Read moreAlzheimer’s patients are in limbo as hospitals, insurers grapple with whether to offer Aduhelm
(By Andrew Joseph and Rachel Cohrs for STAT) For all the explosive controversy over the approval of the first treatment
Read moreA New Alzheimer’s Drug Comes With Lots Of Questions About How To Use It
(By Jon Hamilton for NPR) Nearly two months after the Alzheimer’s drug Aduhelm received conditional approval from the Food and Drug
Read moreFacing Headwinds on New Alzheimer’s Drug, Biogen Launches Controversial Campaign
(By Julie Appleby for Kaiser Health News) Do you sometimes lose your train of thought or feel a bit more
Read moreUnitedHealth CEO: Unknowns of Biogen Alzheimer’s drug mean insurer won’t yet cover it
(By Nick Moran for Becker’s Hospital Review) UnitedHealth Group CEO Andrew Witty said the payer needs to see more data on
Read more